Distinguished Awards

The IASLC's Distinguished Awards are distributed each year to recognize those who have made major contributions to the field of thoracic cancers.  

Paul A. Bunn, Jr. Scientific Award

The Paul A. Bunn, Jr. Scientific Award recognizes an IASLC scientist for lifetime achievement in scientific contributions to thoracic cancer research. Dr. Bunn’s studies have set worldwide standards for the treatment of lung cancer and have identified issues of natural history and biomarkers of prognosis and therapy selection. Robert Ginsberg, MD, a thoracic surgeon from Toronto, Canada, earned the first award in 1994 for his contributions to the surgical treatment of early stage lung cancer. Initially named the Scientific Award, the IASLC renamed the award in honor of Dr. Bunn when he stepped down after serving as its executive director and CEO for 10 years.

Swinton

2018 WINNER: CHARLES SWANTON, MD, PhD 


Charles completed his MD/PhD training in 1999 at the Imperial Cancer Research Fund Laboratories and Cancer Research UK clinician scientist/medical oncology training in 2008. Charles combines his laboratory research at the Francis Crick Institute with clinical duties at UCLH as director of the CRUK UCL Lung Cancer Centre, focused on how tumors evolve over space and time. Charles has helped to define the branched evolutionary histories of solid tumors, processes that drive cancer cell-to-cell variation in the form of new cancer mutations or chromosomal instabilities, and the impact of such cancer diversity on effective immune surveillance and clinical outcome.

Charles was made Fellow of the Royal College of Physicians in April 2011 and appointed Fellow of the Academy of Medical Sciences in 2015. Charles was awarded the Stand up to Cancer Translational Cancer Research Prize (2015), Glaxo Smithkline Biochemical Society Prize (2016), San Salvatore prize for Cancer Research (2017) and the Ellison-Cliffe Medal, Royal Society of Medicine (2017). Charles was appointed Napier Professor in Cancer by the Royal Society in 2016. Charles was elected EMBO member and was appointed the Cancer Research UK Chief Clinician in 2017 and elected a Fellow of the Royal Society in 2018. 

Joseph W. Cullen Prevention/Early Detection Award

The Joseph W. Cullen Prevention/Early Detection Award recognizes an IASLC scientist for lifetime achievement in the prevention of thoracic malignancies. Dr. Cullen served as the deputy director of the National Cancer Institute’s (NCI) Division of Cancer Prevention and Control. He created the Smoking, Tobacco and Cancer Program at the NCI in 1982. The winner of the first award in 1994 was Jesse Steinfeld, MD, the U.S. Surgeon General when the National Cancer Act of 1971 was enacted into federal law.

Khuri

2018 WINNER: FADLO KHURI, MD  

Fadlo R. Khuri, MD is the 16th president of the American University of Beirut. He was elected in March 2015 and assumed office in September 2015. He was Professor and Chairman of the Department of Hematology and Medical Oncology, Emory University School of Medicine, and held the Roberto C. Goizueta Distinguished Chair for Cancer Research. He also served as Deputy Director for the Winship Cancer Institute of Emory University. Dr. Khuri was also the Executive Associate Dean for Research of the Emory University School of Medicine. 

Dr. Khuri was born in Boston, MA and brought up in Beirut, where he attended the American University of Beirut from 1981-82. He moved to the US in 1982, and earned his bachelor’s degree from Yale University, in New Haven, CT, and his MD from Columbia University, College of Physicians and Surgeons, in New York, NY. He completed his residency in Internal Medicine at the Boston City Hospital, Boston, MA, and his fellowship in Hematology and Medical Oncology at the Tufts-New England Medical Center. He was on faculty at the U.T. M.D. Anderson Cancer Center from 1995-2002 prior to joining Emory University and the Winship Cancer Institute (Winship) in 2003.

Wistuba_Ignacio636875803046443348

Mary J. Matthews Pathology/Translational Research Award

The Mary J. Matthews Pathology/Translational Research Award recognizes an IASLC scientist for lifetime achievement in pathology and translational research of thoracic malignancies. Dr. Matthews was a senior investigator and pathologist at the National Cancer Institute’s Medical Oncology Branch. She was pioneer in the foundation of the histologic subtypes of lung cancer and the relationship between those subtypes and the clinical course of lung cancer. The winner of the first award in 1994 was Geno Saccommano, MD, PhD, a physician and cancer researcher who dedicated years of his life to developing a pioneering technique to assist in the early detection of lung cancer

2018 WINNER: IGNACIO I. WISTUBA, MD  

Ignacio I. Wistuba, M.D., is Professor and Chair of the Department of Translational Molecular Pathology, with a joint appointment in Thoracic/Head and Neck Medical Oncology at M.D. Anderson Cancer Center in Houston, TX. He obtained is medical doctor degree in Universidad Austral, Valdivia, Chile (1985), and his surgical pathology training in Catholic University, Santiago, Chile (1989) Dr. Wistuba trained for near five years as post-doctoral research fellow in lung cancer molecular pathology in the Hamon Cancer Center at The University of Texas Southwestern Medical Center under the mentorship of Dr. Adi Gazdar and John Minna (1994-1999). After spending 5 years in Chile as professor of pathology in Catholic University Medical School, he joined MD Anderson Cancer Center in 2003 as associate professor of Pathology and Thoracic/Head and Neck Medical Oncology to lead a lung cancer molecular pathology program. After developing a comprehensive and strong molecular translational pathology for thoracic malignancies at MD Anderson, in 2012 he was named chair of the Department of Translational Molecular Pathology and the Anderson Clinical Faculty Chair for Cancer Treatment and Research.

NY_Photo636875819853524752

Joseph W. Cullen Prevention/Early Detection Award

The Joseph W. Cullen Prevention/Early Detection Award recognizes an IASLC scientist for lifetime achievement in the prevention of thoracic malignancies. Dr. Cullen served as the deputy director of the National Cancer Institute’s (NCI) Division of Cancer Prevention and Control. He created the Smoking, Tobacco and Cancer Program at the NCI in 1982. The winner of the first award in 1994 was Jesse Steinfeld, MD, the U.S. Surgeon General when the National Cancer Act of 1971 was enacted into federal law.

2018 WINNER: NISE YAMAGUCHI, MD  

Nise Yamaguchi is a Brazilian physician who graduated from Faculdade de Medicina da Universidade de São Paulo (FM/USP) in 1982, attended courses and internships in Germany and Switzerland in 1983. After completing her Medical Residency (1984-1986), she participated in scientific exchanges with the Memorial Sloan Kettering Cancer Center in New York and the MD Anderson Cancer Center in Houston. She holds a Master Degree in Immunology (1993) and a Doctor Degree in Clinical Oncology (2002), with specialist titles by the European Society of Allergy and Immunology, and the American Board Certification ECFMGES, European Society of Medical Oncology, Brazilian Society of Clinical Oncology, and Brazilian Medical Association. 

She is also a member of the Clinical Immunology Society since January 2016. She was certified in 2010 by the Harvard School of Medicine for the Course on Principles and Practices of Clinical Trial. Dr. Yamaguchi acted as the head of the São Paulo State Office of the Ministry of Health from 2007 until 2011 and as a member of the International Affairs Committee of the American Society of Clinical Oncology between June 2008 through June 2011, developing academic clinical trials and contributing to the “Low and Middle Income Countries Knowledge Working Group.” 

She currently participates in the design of research (molecular and clinical studies) projects on tumor pharmacogenomics and genetic diversity of the respiratory tract and works as the Clinical Director of the Instituto Avanços em Medicina. She is a hospital doctor at the Oncology Service of Hospital Israelita Albert Einstein (HIAE) in São Paulo, SP, Brazil, where she also participates in the scientific development and clinical meetings, focusing on assistance and continuing medical education. She is currently the Director of Institutional Relations of the Brazilian Association of Medical Women of the State of São Paulo and Brazil. She was appointed for the tenure 2017 - 2020 as Capital Delegate of the Associação Paulista de Medicina the São Paulo State Section of Associação Médica Brasileira (Brazilian Medical Association).